Deregulation of Neuroinflammatory and Neurotrophic Factors as Biological Events Triggered by D-Galactose Chronic Administration in Wistar Rats
- PMID: 40397192
- DOI: 10.1007/s12017-025-08846-0
Deregulation of Neuroinflammatory and Neurotrophic Factors as Biological Events Triggered by D-Galactose Chronic Administration in Wistar Rats
Abstract
The chronic administration of D-galactose (D-gal) is widely used to model brain senescence in rodents. However, the effects of prolonged oral exposure of D-gal on the neuroinflammatory cytokines in rats remain poorly characterized. Therefore, we administered D-gal (100 mg/kg) in male Wistar rats aged 3-4 months, via oral gavage once a day for 1, 2, 4, 6, or 8 weeks. Cytokine and neurotrophin levels were analyzed using the ELISA method. D-gal administrations for 4, 6, and 8 weeks significantly increased interleukin -1β (IL-1β), tumor necrosis factor-alpha (TNF-α), and interleukin-4 (IL-4) levels in the frontal cortex and hippocampus. In addition, 4, 6, and 8 weeks of D-gal administration significantly increased interleukin-10 (IL-10) levels in the frontal cortex; however, in the hippocampus, only 6 and 8 weeks of D-gal administration significantly increased the IL-10 levels. In terms of neurotrophin levels, our results demonstrated that 1 week of D-gal administration significantly increased Brain-derived Neurotrophic Factor (BDNF) and Nerve Growth Factor (NGF) in the hippocampus. In the frontal cortex, D-gal increased BDNF levels when administered for 1 and 2 weeks and increased NGF levels when administered for only 2 weeks. However, we observed a reduction of BDNF, NGF, and Glial cell line-derived Neurotrophic Factor (GDNF) levels after 6 and 8 weeks of D-gal treatment in the frontal cortex. Moreover, GDNF levels also were reduced after 4 weeks of D-gal administration. These findings suggest that oral D-gal exposure disrupts the balance of cytokines and neurotrophins, which may be an essential mechanism in brain aging and neurodegenerative processes.
Keywords: Aging; D-galactose; Inflammatory cytokine; Neurotrophins; Senescence.
© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Conflict of interest: The authors declare no competing interests. Ethical Approval: Attached in the supplementary material. Consent to Participate: Not applicable. Consent for Publication: Not applicable.
Similar articles
-
Prescription of Controlled Substances: Benefits and Risks.2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30726003 Free Books & Documents.
-
Dysregulation of neurotrophin expression in prefrontal cortex and nucleus basalis magnocellularis during and after adolescent intermittent ethanol exposure.Alcohol. 2024 Nov;120:1-14. doi: 10.1016/j.alcohol.2024.06.001. Epub 2024 Jun 17. Alcohol. 2024. PMID: 38897258
-
Effects of polypeptides derived from velvet antler on D-gal induced brain aging model.Int J Biol Macromol. 2025 Aug;320(Pt 1):145659. doi: 10.1016/j.ijbiomac.2025.145659. Epub 2025 Jul 4. Int J Biol Macromol. 2025. PMID: 40618823
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3. Cochrane Database Syst Rev. 2020. Update in: Cochrane Database Syst Rev. 2021 Apr 19;4:CD011535. doi: 10.1002/14651858.CD011535.pub4. PMID: 31917873 Free PMC article. Updated.
References
-
- Ali, A., Shah, S. A., Zaman, N., Uddin, M. N., Khan, W., Ali, A., Riaz, M., & Kamil, A. (2021). Vitamin D exerts neuroprotection via SIRT1/nrf-2/ NF-kB signaling pathways against D-galactose-induced memory impairment in adult mice. Neurochemistry International, 142, 104893. https://doi.org/10.1016/j.neuint.2020.104893 - DOI - PubMed
-
- Azman, K. F., & Zakaria, R. (2019). D-Galactose-induced accelerated aging model: An overview. Biogerontology, 20(6), 763–782. https://doi.org/10.1007/s10522-019-09837-y - DOI - PubMed
-
- Biane, J., Conner, J. M., & Tuszynski, M. H. (2014). Nerve growth factor is primarily produced by GABAergic neurons of the adult rat cortex. Frontiers in Cellular Neuroscience, 8, 220. https://doi.org/10.3389/fncel.2014.00220 - DOI - PubMed - PMC
-
- Budni, J., Bellettini-Santos, T., Mina, F., Garcez, M. L., & Zugno, A. I. (2015). The involvement of BDNF, NGF and GDNF in aging and Alzheimer’s disease. Aging and Disease, 6(5), 331–341. https://doi.org/10.14336/AD.2015.0825 - DOI - PubMed - PMC
-
- Budni, J., Braga Brandão, A., da Silva, S., Lima Garcez, M., Mina, F., Bellettini-Santos, T., Casagrande Zabot, G., Behenck Medeiros, E., Scaini, G., de Oliveira, J., Streck, E. L., & Quevedo, J. (2021). Oral administration of D-galactose increases brain tricarboxylic acid cycle enzymes activities in Wistar rats. Metabolic Brain Disease, 36(5), 1057–1067. https://doi.org/10.1007/s11011-021-00682-y - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources